Correction to: CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib
Crossref DOI link: https://doi.org/10.1007/s00330-020-07592-0
Published Online: 2020-12-15
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Colagrande, S. http://orcid.org/0000-0003-0137-8606
Calistri, L.
Campani, C.
Dragoni, G.
Lorini, C.
Nardi, C.
Castellani, A.
Marra, F.
Text and Data Mining valid from 2020-12-15
Version of Record valid from 2020-12-15
Article History
First Online: 15 December 2020